SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049156
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A onct_defa_14a_2024.htm DEFA14A 16293
2 GRAPHIC img11806325_0.jpg GRAPHIC 1205548
3 GRAPHIC img11806325_1.jpg GRAPHIC 60865
  Complete submission text file 0000950170-24-049156.txt   1760136
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50549 | Film No.: 24883979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)